Page last updated: 2024-11-02

pioglitazone and Hyperlipoproteinemias

pioglitazone has been researched along with Hyperlipoproteinemias in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.

Research Excerpts

ExcerptRelevanceReference
"Simvastatin was well tolerated, and no clinically meaningful differences in the incidence of serious adverse events, treatment-related adverse events, or discontinuations due to adverse events were observed between groups."2.71Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial. ( Kipnes, MS; Lewin, AJ; Maccubbin, DL; Meneghini, LF; Mitchel, YB; Perevozskaya, IT; Plotkin, DJ; Shah, S; Tobert, JA, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewin, AJ1
Kipnes, MS1
Meneghini, LF1
Plotkin, DJ1
Perevozskaya, IT1
Shah, S1
Maccubbin, DL1
Mitchel, YB1
Tobert, JA1

Trials

1 trial available for pioglitazone and Hyperlipoproteinemias

ArticleYear
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Clinical therapeutics, 2004, Volume: 26, Issue:3

    Topics: Adult; Aged; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combina

2004